Back to search
FDAFDA · Food and drugs·Recall number D-0850-2026

Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06

Published September 16, 2026 · Recall initiated: August 17, 2026

Summary

FDA records drug Class I recall D-0850-2026, published September 16, 2026 and initiated August 17, 2026. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 606 bags; Lot: Lot #: Y495066, Exp. Date July 31, 2027. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corporation
Distributor
U.S. Nationwide.
Lot
Lot #: Y495066, Exp. Date July 31, 2027
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06 recalled?

Yes. FDA published recall D-0850-2026 on September 16, 2026. Reported hazard: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter